Literature DB >> 1721421

Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506.

M H Cooper1, P M Markus, X Cai, T E Starzl, J J Fung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721421      PMCID： PMC2981808     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Evaluation of the influence of FK 506, rapamycin, and cyclosporine on processing and presentation of particulate antigen by macrophages: assessment of a drug "carry-over" effect.

Authors:  M H Cooper; S H Gregory; A W Thomson; J J Fung; T E Starzl; E J Wing
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

Authors:  N Murase; S Todo; P H Lee; H S Lai; F Chapman; M A Nalesnik; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

Review 3.  Allogeneic bone-marrow transplantation.

Authors:  R Storb; E D Thomas
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988
  3 in total
  1 in total

1.  Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors.

Authors:  M H Cooper; S H Gregory; T E Starzl; E J Wing
Journal:  Transplantation       Date:  1994-02       Impact factor: 4.939
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.